Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02082977
Title A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell and Transformed Follicular Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

non-Hodgkin lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

GSK126

Age Groups: adult
Covered Countries USA | FRA


No variant requirements are available.